Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF IssuersFidelityFHLC
FHLC

Fidelity MSCI Health Care Index ETF

The Fidelity MSCI Health Care Index ETF, is an exchange-traded fund that tracks the performance of the MSCI USA IMI Health Care Index. This index comprises a broad spectrum of large, medium and small capitalization stocks within the US healthcare sector, offering a diverse exposure to this industry segment. The Fidelity MSCI Health Care Index ETF provides investors an opportunity to participate in the overall performance of the companies included in its managed portfolio. These primarily include pharmaceuticals, biotechnology, and healthcare equipment firms. The exchange-traded fund is constructed to mirror the index it follows, aiming to offer similar returns through direct investments in constituent firms' equities. With its wide-ranging investments spread across different types of healthcare entities, the ETF can be used as a tool for gaining exposure to these respective sub-sectors. The Fidelity MSCI Health Care Index ETF trades on stock exchanges like individual stocks. This characteristic allows flexibility for investors as they can buy or sell this ETF during regular trading hours at market prices. Investment decisions should be made based on an individual's investment objectives and circumstances, keeping in mind that all investment involves risks including potential loss of principal. Please note that this information is provided strictly for informational purposes and should not be considered as investment advice or a recommendation to purchase any particular security. Investors are recommended to consult with their financial advisors before making any investment decisions.

Advertisement

Advertisement

$77.16
-$1.3 (-1.64%) yesterday
1:30 PM 07/14/26 Closed
1D price range
$76.88$77.97
52W price range
$61.57$80.19
YTD Perf.
+6.32%
YTD Flows
Annualized volatility
Fund AuM
€2.88B
Share class AuM
€2.88B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US3160926008
TER
0.084%
Inception date
10/21/2013
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 10, 2026
-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
97.73%
Consumer Non-Cyclicals
1.86%
Unavailable
0.29%
Other
0.12%
Latest FHLC news

No content available for this fund

FAQ about FHLC

FHLC is a Passive ETF. This ETF provides exposure to US Health Care Equities.
FHLC tracks the MSCI USA IMI Health Care 25/50 Index - USD, through a full replication replication method.
FHLC carries a total expense ratio (TER) of 0.084%, indicating the annual cost for holding the fund.
FHLC was introduced to the market on October 21, 2013. It trades on United States
Fidelity MSCI Health Care Index ETF, FHLC, is provided by Fidelity. Learn more about Fidelity here.
FHLC oversees €2.88B in assets as of July 10, 2026.
FHLC follows a distributing dividend policy, meaning it pays out income to investors. As of July 10, 2026, its 12-month trailing yield was 1.30%.
As of May 31, 2026, FHLC has significant geographic allocations in USA and Ireland.
As of May 31, 2026, FHLC focuses largely on Healthcare and Consumer Non-Cyclicals.
As of May 31, 2026, FHLC holds 334 positions in its portfolio, with 61.64% of assets concentrated in its top 15 holdings.
As of May 31, 2026, FHLC top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of FHLC is USD.
Data as of 05/31/26
Eli Lilly & Co.
14.18%
Johnson & Johnson
8.71%
AbbVie, Inc.
6.05%
UnitedHealth Group, Inc.
5.43%
Merck & Co., Inc.
4.66%
Thermo Fisher Scientific, Inc.
2.87%
Amgen, Inc.
2.84%
Gilead Sciences, Inc.
2.65%
Intuitive Surgical, Inc.
2.35%
Abbott Laboratories
2.35%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight